KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Oscar Health (OSCR) EBITDA (2020 - 2025)

Historic EBITDA for Oscar Health (OSCR) over the last 6 years, with Q4 2025 value amounting to -$549.7 million.

  • Oscar Health's EBITDA fell 275300.25% to -$549.7 million in Q4 2025 from the same period last year, while for Dec 2025 it was -$612.3 million, marking a year-over-year decrease of 31527.27%. This contributed to the annual value of -$396.4 million for FY2025, which is 31340.61% down from last year.
  • Per Oscar Health's latest filing, its EBITDA stood at -$549.7 million for Q4 2025, which was down 275300.25% from -$129.2 million recorded in Q3 2025.
  • Over the past 5 years, Oscar Health's EBITDA peaked at $297.1 million during Q1 2025, and registered a low of -$549.7 million during Q4 2025.
  • Over the past 5 years, Oscar Health's median EBITDA value was -$70.5 million (recorded in 2021), while the average stood at -$89.9 million.
  • In the last 5 years, Oscar Health's EBITDA skyrocketed by 41463.83% in 2024 and then tumbled by 275300.25% in 2025.
  • Oscar Health's EBITDA (Quarter) stood at -$196.3 million in 2021, then fell by 13.36% to -$222.5 million in 2022, then tumbled by 59.8% to -$355.5 million in 2023, then soared by 94.58% to -$19.3 million in 2024, then tumbled by 2753.0% to -$549.7 million in 2025.
  • Its last three reported values are -$549.7 million in Q4 2025, -$129.2 million for Q3 2025, and -$230.5 million during Q2 2025.